Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Baggs

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Open Forum Infectious Diseases|June 2, 2025
Trends in Incidence and Epidemiology of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005-2022Holly M Biggs, Rongxia Li, Kelly A Jackson, et al.
Vaccine|May 11, 2005
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Kathleen M Neuzil, Cynthia G Whitney, et al.
MMWR. Morbidity and Mortality Weekly Report|July 28, 2022
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Pediatrics|April 20, 2011
Active surveillance for adverse events: the experience of the Vaccine Safety Datalink projectW Katherine Yih, Martin Kulldorff, Bruce H Fireman, et al.
American Journal of Public Health|October 3, 2009
Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink studyJennifer C Nelson, Rachel C L Bittner, Lora Bounds, et al.
Obstetrics and Gynecology|December 25, 2012
Trivalent inactivated influenza vaccine and spontaneous abortionStephanie A Irving, Burney A Kieke, James G Donahue, et al.
Pediatrics|April 20, 2011
The Vaccine Safety Datalink: a model for monitoring immunization safetyJames Baggs, Julianne Gee, Edwin Lewis, et al.
Vaccine|November 13, 2022
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adultsLindsay K Tompkins, James Baggs, Tanya R Myers, et al.
Archives of Pediatrics & Adolescent Medicine|August 4, 2011
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalinkJason M Glanz, Sophia R Newcomer, Simon J Hambidge, et al.
Journal of Thrombosis and Thrombolysis|December 14, 2022
Association between thromboembolic events and COVID-19 infection within 30 days: a case-control study among a large sample of adult hospitalized patients in the United States, March 2020-June 2021Ya-Lin A Huang, Hussain Yusuf, Alys Adamski, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Open Forum Infectious Diseases|June 2, 2025
Trends in Incidence and Epidemiology of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005-2022Holly M Biggs, Rongxia Li, Kelly A Jackson, et al.
Vaccine|May 11, 2005
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Kathleen M Neuzil, Cynthia G Whitney, et al.
MMWR. Morbidity and Mortality Weekly Report|July 28, 2022
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Pediatrics|April 20, 2011
Active surveillance for adverse events: the experience of the Vaccine Safety Datalink projectW Katherine Yih, Martin Kulldorff, Bruce H Fireman, et al.
American Journal of Public Health|October 3, 2009
Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink studyJennifer C Nelson, Rachel C L Bittner, Lora Bounds, et al.
Obstetrics and Gynecology|December 25, 2012
Trivalent inactivated influenza vaccine and spontaneous abortionStephanie A Irving, Burney A Kieke, James G Donahue, et al.
Pediatrics|April 20, 2011
The Vaccine Safety Datalink: a model for monitoring immunization safetyJames Baggs, Julianne Gee, Edwin Lewis, et al.
Vaccine|November 13, 2022
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adultsLindsay K Tompkins, James Baggs, Tanya R Myers, et al.
Archives of Pediatrics & Adolescent Medicine|August 4, 2011
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalinkJason M Glanz, Sophia R Newcomer, Simon J Hambidge, et al.
Journal of Thrombosis and Thrombolysis|December 14, 2022
Association between thromboembolic events and COVID-19 infection within 30 days: a case-control study among a large sample of adult hospitalized patients in the United States, March 2020-June 2021Ya-Lin A Huang, Hussain Yusuf, Alys Adamski, et al.
Pageof 11